The ‘Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy’ is a forward-looking glimpse into the future of nuclear medicine. The manuscript —published in the January 2021 issue of The Journal of Nuclear Medicine (JNM)—outlines visionary but achievable goals for the many facets of nuclear medicine. The paper was written by a multidisciplinary group of scientists and physicians from the research and discovery domain of the SNMMI’s Value Initiative.
The goal of the SNMMI Mars Shot Research Fund is to support innovative, transformative, nuclear medicine imaging and radiopharmaceutical therapy research. Today, we can prolong lives of patients with cancer with RPTs. Tomorrow, we maybe able to cure cancer in many patients with cutting edge use of imaging and RPT tools.
Help support future innovations in nuclear medicine, molecular imaging, and radiopharmaceutical therapy.
No results returned.